Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aerosolized novaferon versus placebo plus standard of care in hospitalized adults with moderate to severe COVID-19
PACTR202107692340845Phase 3Not yet recruiting
- Sponsor
- Genova
- Start
- Sep 2021
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of novaferon in coronavirus disease 2019 (COVID-19) (3 cohorts), sponsored by Genova. Planned start Sep 2021; status: not yet recruiting.
02
Drugs
novaferon
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on PACTR202107692340845.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202107692340845.